Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 6Unknown 1Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 55Leukemia 35Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma 21Lymphoma, Large B-Cell, Diffuse 18Lymphoma, Non-Hodgkin 13Leukemia, Monocytic, Acute 10Lymphoma, Mantle-Cell 9Leukemia, Myelomonocytic, Acute 9Leukemia, Megakaryoblastic, Acute 8Leukemia, Erythroblastic, Acute 8Recurrence 7Myelodysplastic Syndromes 7Burkitt Lymphoma 7Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, Follicular 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Congenital Abnormalities 5Leukemia, Myeloid, Chronic-Phase 4Hodgkin Disease 4Multiple Myeloma 3Leukemia, Promyelocytic, Acute 3Leukemia, Eosinophilic, Acute 3Leukemia, Basophilic, Acute 3Anemia, Refractory, with Excess of Blasts 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, T-Cell 2Leukemia, Myelomonocytic, Chronic 2

Interventions

Peripheral Blood Stem Cell Transplantation 1Idarubicin 1Etoposide 1Decitabine 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Anemia, Refractory × Cytarabine × Clear all
NCT00002926 2010-05-27

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
80 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡